Your browser doesn't support javascript.
loading
Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin.
Margolis, Jay M; Deitelzweig, Steven; Kline, Jeffrey; Tran, Oth; Smith, David M; Crivera, Concetta; Bookhart, Brahim; Schein, Jeff.
Afiliação
  • Margolis JM; Truven Health Analytics, Bala Cynwyd, Pennsylvania. Electronic address: jay.margolis@truvenhealth.com.
  • Deitelzweig S; Ochsner Health System and The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, Louisiana.
  • Kline J; Carolinas Medical Center, Indianapolis, Indiana.
  • Tran O; Truven Health Analytics, Bethesda, Maryland.
  • Smith DM; Truven Health Analytics, Bethesda, Maryland.
  • Crivera C; Janssen Scientific Affairs LLC, Raritan, New Jersey.
  • Bookhart B; Janssen Scientific Affairs LLC, Raritan, New Jersey.
  • Schein J; Janssen Scientific Affairs LLC, Raritan, New Jersey.
Clin Ther ; 38(11): 2496-2503, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27751675

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Varfarina / Rivaroxabana / Anticoagulantes Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Varfarina / Rivaroxabana / Anticoagulantes Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Ano de publicação: 2016 Tipo de documento: Article